Literature DB >> 15178987

Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study.

Kazumi Kimura1, Seiji Kazui, Kazuo Minematsu, Takenori Yamaguchi.   

Abstract

OBJECTIVE: The purpose of the present study was to clarify the present status of stroke medicine in Japan using a hospital-based, prospective registration study of 156 hospitals from all over Japan.
METHODS: Consecutive patients with acute ischemic stroke and transient ischemic attack (TIA) who presented to hospital within 7 days of onset from May 1999 to April 2000 were enrolled in this study. A common protocol was applied in every participating hospital.
RESULTS: A total of 16,922 patients (TIA, 6.4%) with a mean age of 70.6 +/- 11.5 years (median 71 years, range 18-107 years) were enrolled in the study. Lacunar stroke was the most frequent stroke subtype (38.8%), followed by atherothrombotic (33.3%), cardioembolic (21.8%) and other stroke (6.1%). NIH stroke scale score on admission was 8.0 +/- 7.9 (median 5; 25th to 75th percentile, 2-11). 36.8% arrived at hospital within 3 h of symptom onset, and 49.5% within 6 h. The ambulance was used for 70.2% of patients arriving within 3 h after onset, but in only 29.9% of patients visiting the hospital later than 3 h after onset (p < 0.0001). 60.8% displayed good outcome (modified Rankin Scale score of 0-2 at discharge), while 32.3% displayed poor outcome (score 3-5), and mortality rate was 6.9%.
CONCLUSIONS: More than half of the acute stroke patients arrived at hospital later than 6 h after onset. Establishment of ideal emergency systems is needed for better management of stroke and for improvement of patient outcome, in particular, in the future after approval of intravenous recombinant tissue plasminogen activator for acute ischemic stroke by the Japanese government. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15178987     DOI: 10.1159/000078749

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  25 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.

Authors:  K Kimura; K Minematsu; T Yamaguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

3.  Factors associated with unfavorable outcome in minor ischemic stroke.

Authors:  Shoichiro Sato; Toshiyuki Uehara; Tomoyuki Ohara; Rieko Suzuki; Kazunori Toyoda; Kazuo Minematsu
Journal:  Neurology       Date:  2014-06-06       Impact factor: 9.910

4.  Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke.

Authors:  Saya Ozaki; Mie Kurata; Yoshiaki Kumon; Shirabe Matsumoto; Masahiko Tagawa; Hideaki Watanabe; Shiro Ohue; Jitsuo Higaki; Takanori Ohnishi
Journal:  Hypertens Res       Date:  2016-08-25       Impact factor: 3.872

5.  Is atrial fibrillation associated with poor outcome after thrombolysis?

Authors:  Daniel Sanák; Roman Herzig; Michal Král; Andrea Bártková; Jana Zapletalová; Martin Hutyra; David Skoloudík; Ivanka Vlachová; Tomás Veverka; David Horák; Petr Kanovský
Journal:  J Neurol       Date:  2010-02-02       Impact factor: 4.849

Review 6.  Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.

Authors:  Johan Herlitz; Birgitta Wireklintsundström; Angela Bång; Annika Berglund; Leif Svensson; Christian Blomstrand
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-09-06       Impact factor: 2.953

7.  Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).

Authors:  Naoki Saji; Kazumi Kimura; Yohei Tateishi; Shigeru Fujimoto; Nobuyuki Kaneko; Takao Urabe; Akira Tsujino; Yasuyuki Iguchi
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

Review 8.  Cardiovascular disease and risk factors in Asia: a selected review.

Authors:  Hirotsugu Ueshima; Akira Sekikawa; Katsuyuki Miura; Tanvir Chowdhury Turin; Naoyuki Takashima; Yoshikuni Kita; Makoto Watanabe; Aya Kadota; Nagako Okuda; Takashi Kadowaki; Yasuyuki Nakamura; Tomonori Okamura
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

Review 9.  A comprehensive review of prehospital and in-hospital delay times in acute stroke care.

Authors:  K R Evenson; R E Foraker; D L Morris; W D Rosamond
Journal:  Int J Stroke       Date:  2009-06       Impact factor: 5.266

10.  Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study.

Authors:  Keun Sik Hong; Sun Uck Kwon; Jong Ho Park; Jae Kwan Cha; Jin Man Jung; Yong Jae Kim; Kyung Bok Lee; Sung Il Sohn; Yong Seok Lee; Joung Ho Rha; Jee Hyun Kwon; Sang Won Han; Bum Joon Kim; Jaseong Koo; Jay Chol Choi; Sang Min Sung; Soo Joo Lee; Man Seok Park; Seong Hwan Ahn; Oh Young Bang; Yang Ha Hwang; Hyo Suk Nam; Jong Moo Park; Hee Joon Bae; Eung Gyu Kim; Kyung Yul Lee; Mi Sun Oh
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.